Information disclosure in Ascensia Contour Diabetes

CVE-2018-18977

An issue was discovered in the Ascensia Contour NEXT ONE application for Android before 2019-01-15. An attacker may reverse engineer the codebase to extract sensitive data that contributes to the disclosure of medical information of patients utilizing the Ascensia platform. This occurs because of weak obfuscation.

Vulnerability class: Information Disclosure

Published · last modified .

CVSS v3 metric

CVSS v3 base score 7.5 (High). Vector: CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N.

EPSS exploit prediction

EPSS: 0.016 (74.6th percentile), scored .

Low probability of exploitation in the next 30 days, but still tracked. 75th percentile — 74.6% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2018-18977: held from 0.016 to 0.016.

EPSS over last 30 days · oldest: 0.016 · newest: 0.016 · change: 0.000

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2018-18977?
CVE-2018-18977 is a high-severity vulnerability in Ascensia Contour Diabetes, classified under Information Disclosure. CVSS score: 7.5/10. Published 2019-05-06.
How severe is CVE-2018-18977?
High severity. CVSS v3 base score is 7.5 out of 10.